Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Industrial air pollution and mortality in the Taranto area, Southern Italy: A difference-in-differences approach.

Leogrande S, Alessandrini ER, Stafoggia M, Morabito A, Nocioni A, Ancona C, Bisceglia L, Mataloni F, Giua R, Mincuzzi A, Minerba S, Spagnolo S, Pastore T, Tanzarella A, Assennato G, Forastiere F; CSA Puglia Study Group (see acknowledgements).

Environ Int. 2019 Nov;132:105030. doi: 10.1016/j.envint.2019.105030. Epub 2019 Aug 6.

2.

Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy.

Luberto F, Ferrante D, Silvestri S, Angelini A, Cuccaro F, Nannavecchia AM, Oddone E, Vicentini M, Barone-Adesi F, Cena T, Mirabelli D, Mangone L, Roncaglia F, Sala O, Menegozzo S, Pirastu R, Azzolina D, Tunesi S, Chellini E, Miligi L, Perticaroli P, Pettinari A, Bressan V, Merler E, Girardi P, Bisceglia L, Marinaccio A, Massari S, Magnani C; working group.

Environ Health. 2019 Aug 7;18(1):71. doi: 10.1186/s12940-019-0510-6.

3.

[SENTIERI: Epidemiological Study of Residents in National Priority Contaminated Sites. Fifth Report].

Zona A, Iavarone I, Buzzoni C, Conti S, Santoro M, Fazzo L, Pasetto R, Pirastu R, Bruno C, Ancona C, Bianchi F, Forastiere F, Manno V, Minelli G, Minerba A, Minichilli F, Stoppa G, Pierini A, Ricci P, Scondotto S, Bisceglia L, Cernigliaro A, Ranzi A, Comba P; Gruppo di lavoro SENTIERI; Gruppo di lavoro AIRTUM-SENTIERI; Gruppo di lavoro Malformazioni congenite-SENTIERI.

Epidemiol Prev. 2019 Mar-Jun;43(2-3 Suppl 1):1-208. doi: 10.19191/EP19.2-3.S1.032. Italian.

4.

Mortality for Mesothelioma and Lung Cancer in a Cohort of Asbestos Cement Workers in BARI (Italy): Time Related Aspects of Exposure.

Cuccaro F, Nannavecchia AM, Silvestri S, Angelini A, Coviello V, Bisceglia L, Magnani C.

J Occup Environ Med. 2019 May;61(5):410-416. doi: 10.1097/JOM.0000000000001580.

PMID:
30870398
5.

Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers.

Bianco A, Valletti A, Longo G, Bisceglia L, Montoya J, Emperador S, Guerriero S, Petruzzella V.

BMC Res Notes. 2018 Dec 20;11(1):911. doi: 10.1186/s13104-018-4025-y.

6.

A novel mutation in CDH11, encoding cadherin-11, cause Branchioskeletogenital (Elsahy-Waters) syndrome.

Castori M, Ott CE, Bisceglia L, Leone MP, Mazza T, Castellana S, Tomassi J, Lanciotti S, Mundlos S, Hennekam RC, Kornak U, Brancati F.

Am J Med Genet A. 2018 Sep;176(9):2028-2033. doi: 10.1002/ajmg.a.40379. Epub 2018 Sep 8.

PMID:
30194892
7.

A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.

Nardella G, Visci G, Guarnieri V, Castellana S, Biagini T, Bisceglia L, Palumbo O, Trivisano M, Vaira C, Scerrati M, Debrasi D, D'Angelo V, Carella M, Merla G, Mazza T, Castori M, D'Agruma L, Fusco C.

Hum Mutat. 2018 Dec;39(12):1885-1900. doi: 10.1002/humu.23629. Epub 2018 Sep 24.

PMID:
30161288
8.

Leber's hereditary optic neuropathy, intellectual disability and epilepsy presenting with variable penetrance associated to the m.3460G >A mutation and a heteroplasmic expansion of the microsatellite in MTRNR1 gene - case report.

Bianco A, Bisceglia L, De Caro MF, Galeandro V, De Bonis P, Tullo A, Zoccolella S, Guerriero S, Petruzzella V.

BMC Med Genet. 2018 Jul 27;19(1):129. doi: 10.1186/s12881-018-0644-3.

9.

The effects of the introduction of a chronic care model-based program on utilization of healthcare resources: the results of the Puglia care program.

Robusto F, Bisceglia L, Petrarolo V, Avolio F, Graps E, Attolini E, Nacchiero E, Lepore V.

BMC Health Serv Res. 2018 May 25;18(1):377. doi: 10.1186/s12913-018-3075-0.

10.

Leber's hereditary optic neuropathy (LHON) in an Apulian cohort of subjects.

Bianco A, Bisceglia L, Trerotoli P, Russo L, D'Agruma L, Guerriero S, Petruzzella V.

Acta Myol. 2017 Sep 1;36(3):163-177. eCollection 2017 Sep.

11.

Cystinuria in a 13-month-old Girl with Absence of Mutations in the SLC3A1 and SLC7A9 Genes.

Krishnamurthy S, Pavani C, Kurup PM, Palanisamy S, Jagadeesh A, Sekar K, Mahadevan S, Bisceglia L.

Indian J Nephrol. 2018 Jan-Feb;28(1):84-85. doi: 10.4103/ijn.IJN_20_17. No abstract available.

12.

Cancer incidence estimation method: an Apulian experience.

Nannavecchia AM, Rashid I, Cuccaro F, Chieti A, Bruno D, Burgio Lo Monaco MG, Tanzarella C, Bisceglia L.

Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S153-S156. doi: 10.1097/CEJ.0000000000000374.

13.

High Mitochondrial DNA Copy Number Is a Protective Factor From Vision Loss in Heteroplasmic Leber's Hereditary Optic Neuropathy (LHON).

Bianco A, Bisceglia L, Russo L, Palese LL, D'Agruma L, Emperador S, Montoya J, Guerriero S, Petruzzella V.

Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2193-2197. doi: 10.1167/iovs.16-20389.

PMID:
28403426
14.

Congenital Anomalies in Contaminated Sites: A Multisite Study in Italy.

Santoro M, Minichilli F, Pierini A, Astolfi G, Bisceglia L, Carbone P, Conti S, Dardanoni G, Iavarone I, Ricci P, Scarano G, Bianchi F; RiscRipro Sentieri Working Group.

Int J Environ Res Public Health. 2017 Mar 10;14(3). pii: E292. doi: 10.3390/ijerph14030292.

15.

Expanding the mutation spectrum in 130 probands with ARPKD: identification of 62 novel PKHD1 mutations by sanger sequencing and MLPA analysis.

Melchionda S, Palladino T, Castellana S, Giordano M, Benetti E, De Bonis P, Zelante L, Bisceglia L.

J Hum Genet. 2016 Sep;61(9):811-21. doi: 10.1038/jhg.2016.58. Epub 2016 May 26.

PMID:
27225849
16.

The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level.

Robusto F, Lepore V, D'Ettorre A, Lucisano G, De Berardis G, Bisceglia L, Tognoni G, Nicolucci A.

PLoS One. 2016 Feb 19;11(2):e0149203. doi: 10.1371/journal.pone.0149203. eCollection 2016.

17.

[Childhood cancer incidence in Apulia Region (Southern Italy), 2003-2008].

Cannone GA, Lo Monaco MG, Carone S, Melcarne A, Tanzarella M, Bisceglia L, Ardizzone A, Minerba S, Quarta F, Coviello V; Gruppo di lavoro Registro tumori Puglia.

Epidemiol Prev. 2015;39(3):176-82. Italian.

PMID:
26668917
18.

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus.

Ludovico O, Carella M, Bisceglia L, Basile G, Mastroianno S, Palena A, De Cosmo S, Copetti M, Prudente S, Trischitta V.

PLoS One. 2015 Aug 19;10(8):e0135855. doi: 10.1371/journal.pone.0135855. eCollection 2015.

19.

Mitochondrial DNA copy number differentiates the Leber's hereditary optic neuropathy affected individuals from the unaffected mutation carriers.

Bianco A, Martínez-Romero I, Bisceglia L, D'Agruma L, Favia P, Ruiz-Pesini E, Guerriero S, Montoya J, Petruzzella V.

Brain. 2016 Jan;139(Pt 1):e1. doi: 10.1093/brain/awv216. Epub 2015 Jul 23. No abstract available.

PMID:
26209315
20.

Lower mortality with pre-hospital electrocardiogram triage by telemedicine support in high risk acute myocardial infarction treated with primary angioplasty: Preliminary data from the Bari-BAT public Emergency Medical Service 118 registry.

Brunetti ND, Bisceglia L, Dellegrottaglie G, Bruno AI, Di Pietro G, De Gennaro L, Di Biase M.

Int J Cardiol. 2015 Apr 15;185:224-8. doi: 10.1016/j.ijcard.2015.03.138. Epub 2015 Mar 11. No abstract available.

PMID:
25797682
21.

Development and results of Puglia adult cardiac surgery registry.

Paparella D, Guida P, Bisceglia L, Caparrotti S, Carbone C, Cassese M, Contini M, de Luca Tupputi Schinosa L, De Pasquale C, Di Eusanio G, Fanelli V, Gregorini R, Martinelli G, Mazzei V, Rocco D, Speziale G, Visicchio G, Zaccaria S, Fiore T, Bux F.

J Cardiovasc Med (Hagerstown). 2014 Nov;15(11):810-6. doi: 10.2459/JCM.0000000000000115.

PMID:
24979114
22.

Myocardial damage influences short- and mid-term survival after valve surgery: a prospective multicenter study.

Paparella D, Guida P, Caparrotti S, Fanelli V, Martinelli G, Mazzei V, Zaccaria S, Bisceglia L, Scrascia G.

J Thorac Cardiovasc Surg. 2014 Nov;148(5):2373-2379.e1. doi: 10.1016/j.jtcvs.2013.10.061. Epub 2013 Nov 28.

23.

Estimates of cancer burden in Puglia.

Galise I, Rashid I, Cuccaro F, Bisceglia L, Coviello V, Melcarne A, Minerba S, Mincuzzi A, Assennato G, Foschi R, Rossi S, Gatta G.

Tumori. 2013 May-Jun;99(3):382-9. doi: 10.1700/1334.14803.

PMID:
24158068
24.

Lattice Corneal Dystrophy-Variant: a report of three new cases due to p.V631D mutation in the TGFBI gene.

Laborante A, Longo C, De Bonis P, Bisceglia L.

Clin Ter. 2013;164(1):e41-3. doi: 10.7417/CT.2013.1520.

25.

[Environmental and biological monitoring of exposure to PAHs in Taranto coke-oven workers and in two groups of the general population from Apulia].

Campo L, Vimercati L, Carrus A, Bisceglia L, Pesatori AC, Bertazzi PA, Assennato G, Fustinoni S.

G Ital Med Lav Ergon. 2012 Jul-Sep;34(3 Suppl):655-7. Italian.

PMID:
23405743
26.

20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.

Ciavarella M, Coco M, Baorda F, Stanziale P, Chetta M, Bisceglia L, Palumbo P, Bengala M, Raiteri P, Silengo M, Caldarini C, Facchini R, Lala R, Cavaliere ML, De Brasi D, Pasini B, Zelante L, Guarnieri V, D'Agruma L.

Gene. 2013 Feb 25;515(2):339-48. doi: 10.1016/j.gene.2012.11.055. Epub 2012 Dec 20.

PMID:
23262345
27.

Environmental and biological monitoring of PAHs exposure in coke-oven workers at the Taranto plant compared to two groups from the general population of Apulia, Italy.

Campo L, Vimercati L, Carrus A, Bisceglia L, Pesatori AC, Bertazzi PA, Assennato G, Fustinoni S.

Med Lav. 2012 Sep-Oct;103(5):347-60.

PMID:
23077795
28.

Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients.

Cassandrini D, Cilio MR, Bianchi M, Doimo M, Balestri M, Tessa A, Rizza T, Sartori G, Meschini MC, Nesti C, Tozzi G, Petruzzella V, Piemonte F, Bisceglia L, Bruno C, Dionisi-Vici C, D'Amico A, Fattori F, Carrozzo R, Salviati L, Santorelli FM, Bertini E.

J Inherit Metab Dis. 2013 Jan;36(1):43-53. doi: 10.1007/s10545-012-9487-9. Epub 2012 May 8.

PMID:
22569581
29.

[Health impact assessment of pollution from incinerator in Modugno (Bari)].

Galise I, Serinelli M, Bisceglia L, Assennato G.

Epidemiol Prev. 2012 Jan;36(1):27-33. Italian.

PMID:
22418799
30.

Mutational screening of VSX1, SPARC, SOD1, LOX, and TIMP3 in keratoconus.

De Bonis P, Laborante A, Pizzicoli C, Stallone R, Barbano R, Longo C, Mazzilli E, Zelante L, Bisceglia L.

Mol Vis. 2011;17:2482-94. Epub 2011 Sep 24.

31.

Biomarkers in malignant mesothelioma: diagnostic and prognostic role of soluble mesothelin-related peptide.

Dipalma N, Luisi V, Di Serio F, Fontana A, Maggiolini P, Licchelli B, Mera E, Bisceglia L, Galise I, Loizzi M, Pizzigallo MA, Molinini R, Vimercati L.

Int J Biol Markers. 2011 Jul-Sep;26(3):160-5. doi: 10.5301/JBM.2011.8614. Epub 2011 Sep 5.

PMID:
21928246
32.

Clinical utility gene card for: Cystinuria.

Eggermann T, Zerres K, Nunes V, Font-Llitjós M, Bisceglia L, Chatzikyriakidou A, dello Strologo L, Pras E, Creemers J, Palacin M.

Eur J Hum Genet. 2012 Feb;20(2). doi: 10.1038/ejhg.2011.163. Epub 2011 Aug 24. No abstract available.

33.

Novel human pathological mutations. Gene symbol: SLC3A1. Disease: cystinuria.

Bisceglia L, Fischetti L, De Bonis P.

Hum Genet. 2010 Apr;127(4):489. No abstract available.

PMID:
21491621
34.

Novel human pathological mutations. Gene symbol: SLC3A1. Disease: cystinuria.

Bisceglia L, Fischetti L, De Bonis P.

Hum Genet. 2010 Apr;127(4):488-9. No abstract available.

PMID:
21491620
35.

Novel human pathological mutations. Gene symbol: SLC7A9. Disease: cystinuria.

Bisceglia L, Stanziale P.

Hum Genet. 2010 Apr;127(4):472. No abstract available.

PMID:
21488299
36.

Novel human pathological mutations. Gene symbol: SLC7A9. Disease: cystinuria.

Bisceglia L, Stanziale P.

Hum Genet. 2010 Apr;127(4):472. No abstract available.

PMID:
21488281
37.

Novel human pathological mutations. Gene symbol: SLC3A1. Disease: cystinuria.

Bisceglia L, Stanziale P.

Hum Genet. 2010 Apr;127(4):473. No abstract available.

PMID:
21488254
38.

Novel human pathological mutations. Gene symbol: SLC7A9. Disease: cystinuria.

Bisceglia L, Stanziale P.

Hum Genet. 2010 Apr;127(4):472. No abstract available.

PMID:
21488253
39.

Novel human pathological mutations. Gene symbol: SLC3A1. Disease: cystinuria.

Bisceglia L, Fischetti L.

Hum Genet. 2010 Apr;127(4):472-3. No abstract available.

PMID:
21488235
40.

[Source apportionment of benzo(a)pyrene in Taranto and carcinogenic risk estimate in general population].

Bisceglia L, Giua R, Morabito A, Serinelli M, Calculli C, Galise I, Pollice A, Assennato G.

G Ital Med Lav Ergon. 2010 Oct-Dec;32(4 Suppl):355-6. Italian.

PMID:
21438298
41.

Clinical, biochemical and molecular characterization of cystinuria in a cohort of 12 patients.

Barbosa M, Lopes A, Mota C, Martins E, Oliveira J, Alves S, De Bonis P, Mota Mdo C, Dias C, Rodrigues-Santos P, Fortuna AM, Quelhas D, Lacerda L, Bisceglia L, Cardoso ML.

Clin Genet. 2012 Jan;81(1):47-55. doi: 10.1111/j.1399-0004.2011.01638.x. Epub 2011 Feb 14.

PMID:
21255007
42.

A study of factors influencing urinary arsenic excretion in exposed workers.

Vimercati L, Carrus A, Sciannamblo G, Caputo F, Minunni V, de Nichilo G, Bellotta MR, Gagliardi T, Bisceglia L, Assennato G.

Int J Environ Health Res. 2009 Oct;19(5):369-77. doi: 10.1080/09603120903079349.

PMID:
20183198
43.

A new locus on 3p23-p25 for an autosomal-dominant limb-girdle muscular dystrophy, LGMD1H.

Bisceglia L, Zoccolella S, Torraco A, Piemontese MR, Dell'Aglio R, Amati A, De Bonis P, Artuso L, Copetti M, Santorelli FM, Serlenga L, Zelante L, Bertini E, Petruzzella V.

Eur J Hum Genet. 2010 Jun;18(6):636-41. doi: 10.1038/ejhg.2009.235. Epub 2010 Jan 13.

44.

Large rearrangements detected by MLPA, point mutations, and survey of the frequency of mutations within the SLC3A1 and SLC7A9 genes in a cohort of 172 cystinuric Italian patients.

Bisceglia L, Fischetti L, Bonis PD, Palumbo O, Augello B, Stanziale P, Carella M, Zelante L.

Mol Genet Metab. 2010 Jan;99(1):42-52. doi: 10.1016/j.ymgme.2009.09.001.

PMID:
19782624
45.

[Statistical analysis of the incidence of some cancers in the province of Taranto 1999-2001].

Graziano G, Bilancia M, Bisceglia L, de Nichilo G, Pollice A, Assennato G.

Epidemiol Prev. 2009 Jan-Apr;33(1-2):37-44. Italian.

46.

Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia.

Negro R, Zoccolella S, Dell'aglio R, Amati A, Artuso L, Bisceglia L, Lavolpe V, Papa S, Serlenga L, Petruzzella V.

Neuromuscul Disord. 2009 Jun;19(6):423-6. doi: 10.1016/j.nmd.2009.04.008. Epub 2009 May 9.

PMID:
19428252
47.

Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy.

Pirulli D, Crovella S, Ulivi S, Zadro C, Bertok S, Rendine S, Scolari F, Foramitti M, Ravani P, Roccatello D, Savoldi S, Cerullo G, Lanzilotta SG, Bisceglia L, Zelante L, Floege J, Alexopoulos E, Kirmizis D, Ghiggeri GM, Frascà G, Schena FP, Amoroso A; European IgAN Consortium.

J Nephrol. 2009 Jan-Feb;22(1):152-9.

PMID:
19229831
48.

Linkage analysis in keratoconus: replication of locus 5q21.2 and identification of other suggestive Loci.

Bisceglia L, De Bonis P, Pizzicoli C, Fischetti L, Laborante A, Di Perna M, Giuliani F, Delle Noci N, Buzzonetti L, Zelante L.

Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1081-6. doi: 10.1167/iovs.08-2382. Epub 2008 Oct 31.

PMID:
18978346
49.

An overview of SLC3A1 and SLC7A9 mutations in Greek cystinuria patients.

Chatzikyriakidou A, Louizou E, Dedousis GV, Bisceglia L, Michelakakis H, Georgiou I.

Mol Genet Metab. 2008 Nov;95(3):192-3. doi: 10.1016/j.ymgme.2008.07.006. Epub 2008 Sep 7. No abstract available.

PMID:
18778962
50.

Twenty-four novel mutations identified in a cohort of 85 patients by direct sequencing of the SLC3A1 and SLC7A9 cystinuria genes.

Di Perna M, Louizou E, Fischetti L, Dedoussis GV, Stanziale P, Michelakakis H, Zelante L, Pras E, Bisceglia L.

Genet Test. 2008 Sep;12(3):351-5. doi: 10.1089/gte.2007.0113.

PMID:
18752446

Supplemental Content

Loading ...
Support Center